Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
| 301 | 3 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY//LEVOSIMENDAN//PHARMACOLOGY & PHARMACY | 41522 |
| 980 | 2 | NICORANDIL//CALCIUM ANTAGONISTS//CALCIUM CHANNEL BLOCKERS | 10891 |
| 24354 | 1 | LERCANIDIPINE//LACIDIPINE//LERCANIDIPINE HYDROCHLORIDE | 338 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | LERCANIDIPINE | authKW | 5594603 | 27% | 67% | 90 |
| 2 | LACIDIPINE | authKW | 2535109 | 22% | 37% | 73 |
| 3 | LERCANIDIPINE HYDROCHLORIDE | authKW | 539479 | 3% | 64% | 9 |
| 4 | DELAPRIL | authKW | 221995 | 3% | 24% | 10 |
| 5 | CALCIUM ANTAGONISTS | authKW | 196009 | 17% | 4% | 59 |
| 6 | CAS 132866 11 6 | authKW | 186489 | 1% | 100% | 2 |
| 7 | REC 15 2375 PHARMACOLOGY | authKW | 186489 | 1% | 100% | 2 |
| 8 | MANIDIPINE | authKW | 175917 | 3% | 19% | 10 |
| 9 | HYDROCHLOROTHIAZIDE HCTZ | authKW | 124325 | 1% | 67% | 2 |
| 10 | 1 2 NAPHTHAQUINONE 4 SULPHONIC ACID SODIUM SALT NQS | authKW | 93244 | 0% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 2286 | 48% | 0% | 162 |
| 2 | Cardiac & Cardiovascular System | 1454 | 26% | 0% | 89 |
| 3 | Peripheral Vascular Diseases | 1445 | 20% | 0% | 66 |
| 4 | Medicine, Research & Experimental | 104 | 8% | 0% | 26 |
| 5 | Toxicology | 43 | 4% | 0% | 14 |
| 6 | Medicine, General & Internal | 37 | 7% | 0% | 22 |
| 7 | Chemistry, Analytical | 26 | 5% | 0% | 18 |
| 8 | Chemistry, Medicinal | 13 | 3% | 0% | 9 |
| 9 | Biochemical Research Methods | 12 | 3% | 0% | 10 |
| 10 | Urology & Nephrology | 10 | 2% | 0% | 8 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | ANGIOCARD NEUROL | 93244 | 0% | 100% | 1 |
| 2 | CATEDRA RIESGO CARDIOVASCSERV NEFROL | 93244 | 0% | 100% | 1 |
| 3 | COMPLESSO SOCIO SANIT I | 93244 | 0% | 100% | 1 |
| 4 | FORMAULAT DEV PHARMACOKINET | 93244 | 0% | 100% | 1 |
| 5 | GLAXOWELLCOME S | 93244 | 0% | 100% | 1 |
| 6 | INTERNAL MED THER EUTCLIN MED 2 | 93244 | 0% | 100% | 1 |
| 7 | JUAN F MACIAS HOSP CLIN | 93244 | 0% | 100% | 1 |
| 8 | MED INTERNA AMBROSIONI | 93244 | 0% | 100% | 1 |
| 9 | MED SCI AFFAIRS AUSTRALIA NEW ZEALAND | 93244 | 0% | 100% | 1 |
| 10 | PATHOL L CALIFANO | 93244 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 17115 | 13% | 0% | 45 |
| 2 | JOURNAL OF HYPERTENSION | 8569 | 9% | 0% | 30 |
| 3 | BLOOD PRESSURE | 4597 | 2% | 1% | 7 |
| 4 | KARDIOLOGIYA | 4547 | 5% | 0% | 18 |
| 5 | ACTA THERAPEUTICA | 3378 | 1% | 1% | 3 |
| 6 | RUSSIAN JOURNAL OF CARDIOLOGY | 3166 | 1% | 1% | 4 |
| 7 | CARDIOVASCULAR THERAPY AND PREVENTION | 3119 | 1% | 1% | 5 |
| 8 | CURRENT MEDICAL RESEARCH AND OPINION | 2439 | 3% | 0% | 11 |
| 9 | DRUGS | 2335 | 4% | 0% | 12 |
| 10 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 1934 | 3% | 0% | 10 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |